Date published: 2025-12-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZFP119 Inhibitors

ZFP119 inhibitors are a class of compounds specifically designed to target zinc finger protein 119 (ZFP119), a transcription factor that plays a key role in regulating gene expression by binding to specific DNA sequences. ZFP119, like other zinc finger proteins, contains zinc finger motifs, which are structural domains that allow it to interact with DNA in a highly specific manner. These zinc finger motifs are stabilized by the coordination of zinc ions, which are essential for maintaining the protein's three-dimensional conformation. ZFP119 is involved in modulating the transcription of a variety of genes, influencing important cellular processes. Inhibitors of ZFP119 act by disrupting its ability to bind DNA, either by destabilizing the zinc finger motifs or by preventing the protein from recognizing and binding to its target DNA sequences, ultimately leading to changes in gene regulation.

The mechanisms by which ZFP119 inhibitors exert their effects can vary depending on the chemical properties of the compounds. One common mechanism involves chelating the zinc ions required for the structural stability of the zinc finger domains. By binding to these zinc ions, the inhibitors cause the zinc finger motifs to lose their proper conformation, rendering ZFP119 unable to bind to DNA. This disruption prevents ZFP119 from controlling the transcription of its target genes, thereby affecting cellular pathways that rely on its regulatory activity. Other inhibitors may block protein-protein interactions that are critical for ZFP119's function in forming transcriptional complexes. By inhibiting these interactions, ZFP119 inhibitors further impair the protein's role in gene regulation. The study of ZFP119 inhibitors provides valuable insights into the broader role of zinc finger proteins in gene regulation, contributing to a deeper understanding of transcriptional control and its impact on cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits ZNF119a expression by binding to DNA, preventing RNA polymerase from elongating.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol inhibits ZNF119a expression through its ability to modulate various signaling pathways.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin inhibits ZNF119a by affecting multiple pathways involved in gene expression and protein synthesis.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide inhibits ZNF119a expression by interfering with topoisomerase II, leading to DNA damage and repair.

Ellagic Acid, Dihydrate

476-66-4sc-202598
sc-202598A
sc-202598B
sc-202598C
500 mg
5 g
25 g
100 g
$57.00
$93.00
$240.00
$713.00
8
(1)

Ellagic acid may inhibit ZNF119a by modulating transcription factors and impacting gene expression pathways.

Berberine

2086-83-1sc-507337
250 mg
$90.00
1
(0)

Berberine inhibits ZNF119a through its ability to modulate gene expression and interfere with DNA transcription.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits ZNF119a by targeting cyclin-dependent kinases, which are involved in gene transcription.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin inhibits ZNF119a expression by trapping topoisomerase I-DNA complexes, leading to DNA damage.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Ellipticine inhibits ZNF119a expression by intercalating DNA and affecting the function of DNA topoisomerases.